Letters to the Editor
Anakinra in COVID-19 therapy: what have we learned from adult-onset Still’s disease?
S. Bilia1, D. Giannini2, G.M.L. Rizzelli3, A. Tavoni4
- Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Emergency Department, Nuovo Santa Chiara Hospital, U.O. Medicina d’Urgenza e Pronto Soccorso, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
- Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. a.tavoni@int.med.unipi.it
CER13482
2020 Vol.38, N°3
PI 0579
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 32456767 [PubMed]
Received: 22/04/2020
Accepted : 11/05/2020
In Press: 27/05/2020
Published: 27/05/2020
